|
|
|
|
||
Alnylam Announces 2020 Product and Pipeline Goals and Provides Updates at R&D Day"Over the course of 2020 we expect to deliver on a Company profile with four medicines on the market, assuming additional regulatory approvals, while also advancing a large number of late- and earlier-stage programs, all while focusing on our pathway toward a self-sustainable financial profile." John Maraganore |
return to message board, top of board |